Organon & Co OGN:NYSE

RT Quote | NYSE | USD
Last | 01/24/22 EST
30.45quote price arrow down-0.52 (-1.68%)
Volume
2,578,034
52 week range
27.25 - 38.75
Loading...
  • Open30.32
  • Day High30.63
  • Day Low28.94
  • Prev Close30.45
  • 52 Week High38.75
  • 52 Week High Date05/25/21
  • 52 Week Low27.25
  • 52 Week Low Date06/09/21

Key Stats

  • Market Cap7.721B
  • Shares Out253.55M
  • 10 Day Average Volume2.00M
  • Dividend1.12
  • Dividend Yield3.68%
  • Beta-
  • YTD % Change-

KEY STATS

  • Open30.32
  • Day High30.63
  • Day Low28.94
  • Prev Close30.45
  • 52 Week High38.75
  • 52 Week High Date05/25/21
  • 52 Week Low27.25
  • 52 Week Low Date06/09/21
  • Market Cap7.721B
  • Shares Out253.55M
  • 10 Day Average Volume2.00M
  • Dividend1.12
  • Dividend Yield3.68%
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)6.66
  • P/E (TTM)4.57
  • Fwd P/E (NTM)5.30
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-574.66%

EVENTS

  • Earnings Date-
  • Ex Div Date11/19/2021
  • Div Amount0.28
  • Split Date-
  • Split Factor-

Latest On Organon & Co

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Organon & Co. (Organon) is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. Organon has a portfolio of contraception and fertility brands, such as Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also...
Address
30 Hudson Street, Fl 33
Jersey City, NJ
07302
United States